Home Stocks Eris Lifesciences Ltd

Eris Lifesciences Ltd

The live share price of Eris Lifesciences Ltd (ERIS) as on 29 Apr 5:31am is ₹897.55 from NSE/BSE.

ERIS NSE

₹897.55 ▲0.52% (4.6)

As on Apr 29, 2024 11:01 AM IST

How do you feel today about Eris Lifesciences Ltd?

Bearish or

Bullish

Bearish or

Bullish

Key Metrics

PE Ratio

31.44

PB Ratio

5.47

Dividend Yield

0.82%

Sector PB

5.97

Sector PE

53.11

Sector Div Yld

0.54%

Dividend Yield

Dividend per share for the most recent financial year divided by the close price

About

Sector

Health Care

Industry

Pharmaceuticals

Market Cap

Smallcap, ₹12,148 Cr

Eris Lifesciences Limited is engaged in manufacturing, marketing and selling of generics within the chronic and acute categories of the Indian Pharmaceutical Market

The following charts display the financial performance of the Eris Lifesciences Ltd (ERIS) stock, including the year-on-year Income Statement , Balance Sheet , Cash Flow Statement and Shareholding pattern.

Furthermore, under the Peers section, you can find stocks that are similar to Eris Lifesciences Ltd (ERIS), and their live stock price and performance at a glance. Click on any peer stock to navigate to that stock’s live price page.

✅ If you’re new to investing in the stock market, and/or are unsure about your investment options, you can explore smallcases.

A smallcase is a readymade stock/ETF portfolio (also known as a stock basket) that is based on an investment idea, theme or strategy. Examples of popular smallcases include All Weather Investing , Equity and Gold , Top 100 Stocks , Green Energy and Value & Momentum.

All smallcases are created and managed by SEBI-registered investment experts.

To invest in smallcases, all you need is a demat/trading account. You retain complete ownership of the smallcase’s constituent stocks or ETFs, as they are directly credited to your broking account. You can choose from over 500+ smallcases across 180+ smallcase managers to start your investment journey.

Sector

Health Care

Industry

Pharmaceuticals

Market Cap

Smallcap, ₹12,148 Cr

Financials

Income Statement

(INR)		Y/Y Change
Revenue	1,696 Cr	+23.54%
Operating Expense	119 Cr	+29.72%
Net Income	382 Cr	-5.9%
Net Profit Margin	22.53%	-23.83%
Earning Per Share	28	-5.96%
EBITDA	548 Cr	+7.23%

Balance sheet

(INR)		Y/Y Change
Cash & short-term Inv	88 Cr	-41.75%
Total Assets	3,409 Cr	+53.17%
Total Liabilities	1,189 Cr	+274.08%
Total Equity	2,220 Cr	+16.38%
Shares Outstanding	13.6 Cr	+0.05%
Price to Book	3.5	-30.21%
Return on Assets	13.56%	-33.04%
Return on Capital	19.41 Cr	-17.02%

Cash Flows

(INR)		Y/Y Change
Net Income	382 Cr	-5.9%
Cash from Operations	291 Cr	-22.87%
Cash from Investing	-974 Cr	+204.94%
Cash from Financing	688 Cr	-1639.22%
Net Change in Cash	5 Cr	-63.01%
Free Cash Flow	-549 Cr	-313.69%

Shareholding Pattern

Total Promoter Holding

54.9%

Unpledged

Foreign Institutions

14.27%

Foreign Institutions

Retail & Others

15.2%

Retail & Others

Other Parties

Other Domestic Institutions

0.71%

Insurance Firms

Others

Mutual Funds

14.92%

Mutual Funds

Peers

SUNPHARMA

Sun Pharmaceutical Industries Ltd

PE Ratio

40.59

1Y Return

▲52.54%

CIPLA

Cipla Ltd

PE Ratio

30.68

1Y Return

▲55.18%

DRREDDY

Dr Reddy's Laboratories Ltd

PE Ratio

19.91

1Y Return

▲26.82%

ZYDUSLIFE

Zydus Lifesciences Ltd

PE Ratio

32.06

1Y Return

▲82.23%

Latest News

Neutral Eris Lifesciences; target of Rs 930: Motilal Oswal

1 month ago on Moneycontrol

Change since news ▼-INF%

Motilal Oswal recommended Neutral rating on Eris Lifesciences with a target price of Rs 930 in its research report dated March 14, 2024.

Biocon stock falls 4% after subsidiary sells branded formulations biz to Eris Lifesciences

2 months ago on Moneycontrol

Change since news ▼-INF%

Biocon Biologics said that it has entered into a long-term commercial collaboration with Eris Lifesciences to expand patient access to its portfolio of Metabolics, Oncology, and Critical Care products in India.

Eris Lifesciences trades lower after buying branded formulation business of Biocon Biologics

2 months ago on Moneycontrol

Change since news ▼-INF%

Broking house Motilal Oswal maintained neutral on Eris Lifesciences with a price target of Rs 930.

Eris Lifesciences - Acquisition To Expand Diabetes Offerings, Add Oncology Products: Motilal Oswal

2 months ago on Bloomberg Quint

Change since news ▼-INF%

Execution remains key over next 15-18 months

Eris Lifesciences Acquires Biocon Biologics’ Indian Branded Formulations Business

2 months ago on Bloomberg Quint

Change since news ▼-INF%

The acquisition will expand Eris’ presence in the India-branded sterile injectables market.

Eris Lifesciences, Alkem, Mankind, Torrent Pharma - Steady Growth Story: HDFC Securities Initiates Coverage

2 months ago on Bloomberg Quint

Change since news ▼-INF%

Domestic formulations sector, secular growth stories

FAQs on Eris Lifesciences Ltd

How to buy Eris Lifesciences Ltd stocks?

You can easily buy the stocks/shares of Eris Lifesciences Ltd (ERIS) through either a broker or a financial institution by opening a Demat & Trading account online via smallcase.

What is the Share Price of Eris Lifesciences Ltd?

The stock price of Eris Lifesciences Ltd as on 29 Apr 2024 is ₹897.55

What is the 52-week High and Low of Eris Lifesciences Ltd?

The 52-week high and low of Eris Lifesciences Ltd (ERIS) is ₹971.9 and ₹604.4.

What is the PE and PB ratio of Eris Lifesciences Ltd?

The P/E (price-to-earnings) and P/B (price-to-book) ratios of Eris Lifesciences Ltd are 31.44 and 5.47 respectively.

What are the peers or stocks similar to Eris Lifesciences Ltd?

The peers or stocks similar to Eris Lifesciences Ltd are Sun Pharmaceutical Industries Ltd, Cipla Ltd, Dr Reddy's Laboratories Ltd, Zydus Lifesciences Ltd and many others. smallcase also offers over 200 readymade stock baskets managed by 180+ SEBI-registered investment experts. These stock portfolios are based on a theme, idea or strategy. You can use smallcase to start investing in diversified stock baskets.

Which sector does Eris Lifesciences Ltd belong to?

Eris Lifesciences Ltd (ERIS) belongs to the Pharmaceuticals sector.

What is the Market Cap of Eris Lifesciences Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Eris Lifesciences Ltd (ERIS) is ₹12,148 Cr as of 29 Apr 2024

Can't decide whether or not to buy Eris Lifesciences Ltd stocks? ⭐️

Worry no more! smallcase offers readymade stock baskets/portfolios that are based on an theme, idea or strategy. You can choose from more than 500+ stock portfolios managed by 180+ SEBI-registered investment experts.

Dislaimer: This platform is intended for informational purposes only and is not intended to provide investment advice. The stock prices displayed are delayed and may not reflect the most current market conditions. Investment in securities market are subject to market risks. Read all the related documents carefully before investing. You can also consider consulting a financial advisor before making any investment decisions. Smallcase Technologies Private Limited shall not be responsible for any losses that may occur as a result of using this platform.